Search by Drug Name or NDC

    NDC 45802-0263-37 Clindamycin Phosphate 10 mg/mL Details

    Clindamycin Phosphate 10 mg/mL

    Clindamycin Phosphate is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is CLINDAMYCIN PHOSPHATE.

    Product Information

    NDC 45802-0263
    Product ID 45802-263_e92b0367-c4ed-4147-b5f5-0c6afa71b1bd
    Associated GPIs 90051010109420
    GCN Sequence Number 022140
    GCN Sequence Number Description clindamycin phosphate MED. SWAB 1 % TOPICAL
    HIC3 Q5W
    HIC3 Description TOPICAL ANTIBIOTICS
    GCN 45411
    HICL Sequence Number 004045
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE
    Brand/Generic Generic
    Proprietary Name Clindamycin Phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Clindamycin Phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route TOPICAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/mL
    Substance Name CLINDAMYCIN PHOSPHATE
    Labeler Name Padagis Israel Pharmaceuticals Ltd
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA065049
    Listing Certified Through 2024-12-31

    Package

    NDC 45802-0263-37 (45802026337)

    NDC Package Code 45802-263-37
    Billing NDC 45802026337
    Package 60 APPLICATOR in 1 JAR (45802-263-37) / 1 mL in 1 APPLICATOR
    Marketing Start Date 2006-05-31
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.32069
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description CLINDAMYCIN PHOS 1% PLEDGET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis